Auto-generated event page
Supernus Pharmaceuticals to Participate in March Investor Conferences
ROCKVILLE, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products f...
Score 33
low confidence
3 source posts
Updated Feb 23, 2026, 11:20 PM UTC